Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial | Trials | Full Text

Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial | Trials | Full Text

Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial

An amendment to this paper has been published and can be accessed via the original article.

Authors:Javed Akram, Shehnoor Azhar, Muhammad Shahzad, Waqas Latif and Khalid Saeed Khan

Citation:Trials 2020 21:733

Content type:Correction

 

Published on: 22 August 2020

The original article was published in Trials 2020 21:702

• ViewFull Text
 
• ViewPDF